WallStSmart

Churchill Capital Corp XI (CCXI)vsK&F Growth Acquisition Corp. II Class A Ordinary shares (KFII)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

KFII leads profitability with a 0.0% profit margin vs 0.0%. KFII earns a higher WallStSmart Score of 32/100 (F).

CCXI

Avoid

24

out of 100

Grade: F

Growth: 4.3Profit: 4.0Value: 5.0Quality: 6.0
Piotroski: 2/9

KFII

Avoid

32

out of 100

Grade: F

Growth: 4.3Profit: 3.5Value: 4.7Quality: 6.0
Piotroski: 3/9

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCXI0 strengths · Avg: 0/10

No standout strengths identified

KFII0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

CCXI4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$805.98M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
4.7%3/10

ROE of 4.7% — below average capital efficiency

KFII4 concerns · Avg: 3.8/10
P/E RatioValuation
37.8x4/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
4.2%4/10

4.2% earnings growth

Market CapQuality
$415.72M3/10

Smaller company, higher risk/reward

Comparative Analysis Report

WallStSmart Research

Bull Case : CCXI

CCXI has a balanced fundamental profile.

Bull Case : KFII

KFII has a balanced fundamental profile.

Bear Case : CCXI

The primary concerns for CCXI are Revenue Growth, EPS Growth, Market Cap.

Bear Case : KFII

The primary concerns for KFII are P/E Ratio, Revenue Growth, EPS Growth.

Key Dynamics to Monitor

KFII is growing revenue faster at 0.0% — sustainability is the question.

KFII generates stronger free cash flow (-278,286), providing more financial flexibility.

Monitor SHELL COMPANIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

KFII scores higher overall (32/100 vs 24/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Churchill Capital Corp XI

FINANCIAL SERVICES · SHELL COMPANIES · USA

ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company is headquartered in Mountain View, California.

K&F Growth Acquisition Corp. II Class A Ordinary shares

FINANCIAL SERVICES · SHELL COMPANIES · USA

K&F Growth Acquisition Corp. The company is headquartered in Manhattan Beach, California.

Want to dig deeper into these stocks?